// App-Quantinova.ai

1581 : Circulating tumor DNA mutational profiling by targeted next generation sequencing guides personalized treatments in multiple cancer types.

Researchers

Presenter

  • Yang Shao

Principal Investigators

  • Xiaoling Tong

  • Xiaonan Wang

  • Zhili Chang

  • Yu Mao

  • Xue Wu

Medical Centers

  • University of Toronto, Toronto, ON, Canada

  • Geneseeq Technology Inc., Toronto, ON, Canada

  • Geneseeq Technology Inc., Nanjing, China

Locations

  • Canada

  • China

Companies

  • Geneseeq Technology

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Circulating DNA

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final